Wirkung von Betablockern beim triple-negativen Mammakarzinom

C.H. Storch, P.H. Hoeger, Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. British Journal of Dermatology. ,vol. 163, pp. 269- 274 ,(2010) , 10.1111/J.1365-2133.2010.09848.X

Christine Léauté-Labrèze, Eric Dumas de la Roque, Thomas Hubiche, Franck Boralevi, Jean-Benoît Thambo, Alain Taïeb, Propranolol for Severe Hemangiomas of Infancy The New England Journal of Medicine. ,vol. 358, pp. 2649- 2651 ,(2008) , 10.1056/NEJMC0708819

E Pasquier, J Street, C Pouchy, M Carre, AJ Gifford, J Murray, MD Norris, T Trahair, N Andre, M Kavallaris, None, β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma. British Journal of Cancer. ,vol. 108, pp. 2485- 2494 ,(2013) , 10.1038/BJC.2013.205

Desmond G. Powe, Frank Entschladen, Targeted therapies: Using β-blockers to inhibit breast cancer progression. Nature Reviews Clinical Oncology. ,vol. 8, pp. 511- 512 ,(2011) , 10.1038/NRCLINONC.2011.123

Edoardo Botteri, Elisabetta Munzone, Nicole Rotmensz, Carlo Cipolla, Vincenzo De Giorgi, Barbara Santillo, Arnaldo Zanelotti, Laura Adamoli, Marco Colleoni, Giuseppe Viale, Aron Goldhirsch, Sara Gandini, Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women. Breast Cancer Research and Treatment. ,vol. 140, pp. 567- 575 ,(2013) , 10.1007/S10549-013-2654-3

J.W Black, A.F Crowther, R.G Shanks, L.H Smith, A.C Dornhorst, A NEW ADRENERGIC: BETA-RECEPTOR ANTAGONIST The Lancet. ,vol. 283, pp. 1080- 1081 ,(1964) , 10.1016/S0140-6736(64)91275-9

Vincenzo De Giorgi, Sara Gandini, Marta Grazzini, Silvia Benemei, Niccolò Marchionni, Pierangelo Geppetti, Effect of β-blockers and other antihypertensive drugs on the risk of melanoma recurrence and death. Mayo Clinic proceedings. ,vol. 88, pp. 1196- 1203 ,(2013) , 10.1016/J.MAYOCP.2013.09.001

Jing Tang, Zhijie Li, Lan Lu, Chi Hin Cho, β-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy Seminars in Cancer Biology. ,vol. 23, pp. 533- 542 ,(2013) , 10.1016/J.SEMCANCER.2013.08.009

Kashif Kalam, Thomas H. Marwick, Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: A systematic review and meta-analysis European Journal of Cancer. ,vol. 49, pp. 2900- 2909 ,(2013) , 10.1016/J.EJCA.2013.04.030

Erica K. Sloan, Saul J. Priceman, Benjamin F. Cox, Stephanie Yu, Matthew A. Pimentel, Veera Tangkanangnukul, Jesusa M.G. Arevalo, Kouki Morizono, Breanne D.W. Karanikolas, Lily Wu, Anil K. Sood, Steven W. Cole, The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Research. ,vol. 70, pp. 7042- 7052 ,(2010) , 10.1158/0008-5472.CAN-10-0522